Re.: '"Now that RECAF is about to be commercialized, BOCX is going to begin focusing their resources on something so huge it is hard for me to explain. BOCX will be able to use a radiotag in conjunction with the RECAF test to locate exactly where the cancer is and track if it spreads."
The above quote from Lebed is not widely known and especially from someone so new to the stock so I think he really did speak with Wittenberg.'
Hardly. This is apparently their imaging technology, which in contrast to what you suggest, they have been talking about for years. Lebed just needed to read the PRs to learn about it.
News 
Market Data 
Discover 
